Kymera Therapeutics, Inc.
USD73.21
+1.92 (+2.69%)
CEO
Nello Mainolfi
IPO Date
2020-08-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$70.99
Prev. Close
$71.29
Day Low
$69.48
Day High
$73.94
52W Low
$36.65
52W High
$103.00
Market Cap
$6.02B
Volume
0.85M
| 324 |
| $79.17 |
| 27 May 2026 | Chadwick Jeremy G | Chief Operating Officer | S-Sale | Disposed | 3,800 | $79.39 |
| 27 May 2026 | Chadwick Jeremy G | Chief Operating Officer | S-Sale | Disposed | 4,500 | $80.02 |
| 27 May 2026 | Chadwick Jeremy G | Chief Operating Officer | S-Sale | Disposed | 551 | $80.71 |
| 27 May 2026 | Chadwick Jeremy G | Chief Operating Officer | S-Sale | Disposed | 3,679 | $81.50 |
| 27 May 2026 | Chadwick Jeremy G | Chief Operating Officer | S-Sale | Disposed | 600 | $82.08 |
| 19 May 2026 | Esposito Pamela | director | M-Exempt | Acquired | 1,000 | $31.20 |
| 19 May 2026 | Esposito Pamela | director | M-Exempt | Disposed | 1,000 | $31.20 |
| 19 May 2026 | Jacobs Bruce N. | Chief Financial Officer | M-Exempt | Acquired | 15,000 | $2.08 |